Suppr超能文献

相似文献

1
Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
J Hepatol. 2014 Oct;61(4):912-24. doi: 10.1016/j.jhep.2014.05.047. Epub 2014 Jun 6.
2
Pathophysiology of portal hypertension.
Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25.
3
Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.
Liver Int. 2012 Feb;32(2):199-213. doi: 10.1111/j.1478-3231.2011.02579.x. Epub 2011 Jul 5.
4
Pathophysiology and a Rational Basis of Therapy.
Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6.
5
Biology of portal hypertension.
Hepatol Int. 2018 Feb;12(Suppl 1):11-23. doi: 10.1007/s12072-017-9826-x. Epub 2017 Oct 26.
6
[Pathogenesis of portal hypertension].
Rev Invest Clin. 2005 Jul-Aug;57(4):596-607.
7
Hemodynamic alterations in cirrhosis and portal hypertension.
Korean J Hepatol. 2010 Dec;16(4):347-52. doi: 10.3350/kjhep.2010.16.4.347.
8
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
J Mol Med (Berl). 2019 Mar;97(3):423-434. doi: 10.1007/s00109-019-01746-4. Epub 2019 Feb 5.
9
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555.
10
Vascular deterioration in cirrhosis: the big picture.
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S247-53. doi: 10.1097/MCG.0b013e3181572357.

引用本文的文献

1
Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway.
Adv Pharm Bull. 2025 Feb 12;15(1):107-122. doi: 10.34172/apb.43295. eCollection 2025 Apr.
2
Liver macrophages: development, dynamics, and functions.
Cell Mol Immunol. 2025 Jun 3. doi: 10.1038/s41423-025-01298-3.
3
4
Fibrosis: cross-organ biology and pathways to development of innovative drugs.
Nat Rev Drug Discov. 2025 Mar 18. doi: 10.1038/s41573-025-01158-9.
8
Cigarette smoking and alcohol-related liver disease.
Liver Res. 2024 Dec 5;8(4):237-245. doi: 10.1016/j.livres.2024.12.002. eCollection 2024 Dec.

本文引用的文献

3
Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.
Gastroenterology. 2014 May;146(5):1339-50.e1. doi: 10.1053/j.gastro.2014.01.061. Epub 2014 Feb 4.
5
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.
Nature. 2014 Jan 2;505(7481):97-102. doi: 10.1038/nature12681. Epub 2013 Nov 20.
6
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs.
Nat Med. 2013 Dec;19(12):1617-24. doi: 10.1038/nm.3282. Epub 2013 Nov 10.
7
Smooth muscle α actin (Acta2) and myofibroblast function during hepatic wound healing.
PLoS One. 2013 Oct 29;8(10):e77166. doi: 10.1371/journal.pone.0077166. eCollection 2013.
9
The lymphatic vascular system in liver diseases: its role in ascites formation.
Clin Mol Hepatol. 2013 Jun;19(2):99-104. doi: 10.3350/cmh.2013.19.2.99. Epub 2013 Jun 27.
10
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Gastroenterology. 2013 Oct;145(4):874-884.e5. doi: 10.1053/j.gastro.2013.06.036. Epub 2013 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验